Emilie Jouanjus



  1. Lafaurie M, Pochard L, Lotiron C, Molinier L, Lapeyre Mestre M, Jouanjus E. Identification of Somatic Disorders Related to Psychoactive Drug Use from an Inpatient Database in a French University Hospital. Clin Drug Investig. 2018;38:977-982 pubmed publisher
    ..This method should be applied in other hospital settings before considering the exploration of inpatient data on a wider scale. ..
  2. Bossard J, Ponté C, Dupouy J, Lapeyre Mestre M, Jouanjus E. Disproportionality Analysis for the Assessment of Abuse and Dependence Potential of Pregabalin in the French Pharmacovigilance Database. Clin Drug Investig. 2016;36:735-742 pubmed publisher
    ..Considering evidence of pregabalin abuse worldwide, this analysis underlines the limitations of spontaneous reporting system in the field of addictovigilance. ..
  3. Wolff V, Jouanjus E. Strokes are possible complications of cannabinoids use. Epilepsy Behav. 2017;70:355-363 pubmed publisher
    ..This article is part of a Special Issue entitled "Cannabinoids and Epilepsy". ..
  4. Jouanjus E, Raymond V, Lapeyre Mestre M, Wolff V. What is the Current Knowledge About the Cardiovascular Risk for Users of Cannabis-Based Products? A Systematic Review. Curr Atheroscler Rep. 2017;19:26 pubmed publisher
    ..While the data are limited, there is some suggestion that cannabis use may have negative cardiovascular consequences, particularly at large doses. ..